1. Home
  2. UG vs BOLD Comparison

UG vs BOLD Comparison

Compare UG & BOLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo United-Guardian Inc.

UG

United-Guardian Inc.

HOLD

Current Price

$6.62

Market Cap

27.7M

ML Signal

HOLD

Logo Boundless Bio Inc.

BOLD

Boundless Bio Inc.

HOLD

Current Price

$1.11

Market Cap

28.4M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
UG
BOLD
Founded
1942
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Package Goods/Cosmetics
Sector
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
27.7M
28.4M
IPO Year
N/A
2024

Fundamental Metrics

Financial Performance
Metric
UG
BOLD
Price
$6.62
$1.11
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$4.00
AVG Volume (30 Days)
14.9K
178.1K
Earning Date
03-20-2026
03-26-2026
Dividend Yield
7.47%
N/A
EPS Growth
N/A
N/A
EPS
0.43
N/A
Revenue
$10,060,322.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$15.68
N/A
Revenue Growth
N/A
N/A
52 Week Low
$5.58
$0.96
52 Week High
$11.08
$2.48

Technical Indicators

Market Signals
Indicator
UG
BOLD
Relative Strength Index (RSI) 49.31 41.13
Support Level $6.25 $0.96
Resistance Level $7.41 $1.20
Average True Range (ATR) 0.31 0.07
MACD -0.04 -0.01
Stochastic Oscillator 32.58 45.40

Price Performance

Historical Comparison
UG
BOLD

About UG United-Guardian Inc.

United-Guardian Inc manufactures and markets cosmetic ingredients, pharmaceuticals, medical lubricants, and specialty industrial products. Its product portfolio includes Klensoft, Deselex, Renacidin, Lubrajel Fluid. The company's pharmaceutical products are sold to and distributed by full-line drug wholesalers throughout the United States. Its medical and specialty industrial products are sold directly by the company to the end-users of those products or, in some cases, to contract manufacturers used by some of those end users. It operates in one business segment and its current product lines are separated into four distinct product categories that are cosmetic ingredients, pharmaceuticals, medical lubricants and sexual wellness. It derives key revenue from the sales made in the U.S.

About BOLD Boundless Bio Inc.

Boundless Bio Inc is a clinical-stage oncology company. The company is dedicated to unlocking a new paradigm in cancer therapeutics that addresses the unmet need in patients with oncogene-amplified tumors by targeting extrachromosomal DNA (ecDNA), a root cause of oncogene amplification observed in cancer patients. Its ecDTx, BBI-355, is a novel, oral, selective inhibitor of checkpoint kinase 1 (CHK1), which manages ecDNA replication and transcription in cancer cells.

Share on Social Networks: